Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $3.79 $4.95 Wednesday, 8th May 2024 ALDX stock ended at $4.07. This is 2.40% less than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 2.97% from a day low at $4.05 to a day high of $4.17.
90 days $2.71 $4.97
52 weeks $1.42 $11.97

Historical Aldeyra Therapeutics prices

Date Open High Low Close Volume
Jan 23, 2023 $6.28 $6.32 $6.07 $6.11 257 525
Jan 20, 2023 $6.19 $6.36 $6.08 $6.32 254 200
Jan 19, 2023 $6.03 $6.16 $5.97 $6.10 315 525
Jan 18, 2023 $6.25 $6.37 $6.05 $6.07 380 500
Jan 17, 2023 $6.41 $6.52 $6.24 $6.25 282 380
Jan 13, 2023 $6.70 $6.90 $6.42 $6.45 336 839
Jan 12, 2023 $6.41 $6.80 $6.28 $6.77 239 200
Jan 11, 2023 $6.42 $6.44 $6.16 $6.31 259 300
Jan 10, 2023 $6.36 $6.52 $6.19 $6.44 469 729
Jan 09, 2023 $7.02 $7.10 $6.26 $6.37 533 829
Jan 06, 2023 $6.99 $7.19 $6.75 $6.98 651 100
Jan 05, 2023 $6.79 $7.07 $6.78 $7.04 249 726
Jan 04, 2023 $7.06 $7.14 $6.82 $6.91 435 561
Jan 03, 2023 $7.01 $7.08 $6.78 $6.96 398 078
Dec 30, 2022 $7.06 $7.06 $6.72 $6.96 271 168
Dec 29, 2022 $6.69 $7.15 $6.64 $7.09 444 127
Dec 28, 2022 $6.59 $6.75 $6.43 $6.62 235 025
Dec 27, 2022 $6.69 $6.76 $6.43 $6.61 476 017
Dec 23, 2022 $6.48 $6.62 $6.38 $6.60 278 768
Dec 22, 2022 $6.46 $6.51 $6.16 $6.49 461 498
Dec 21, 2022 $6.15 $6.58 $5.95 $6.48 721 285
Dec 20, 2022 $6.07 $6.25 $6.07 $6.10 137 094
Dec 19, 2022 $6.38 $6.40 $5.96 $6.08 299 468
Dec 16, 2022 $6.21 $6.37 $6.17 $6.32 309 256
Dec 15, 2022 $6.10 $6.25 $6.03 $6.22 233 256
Click to get the best stock tips daily for free!

About Aldeyra Therapeutics

Aldeyra Therapeutics Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical tria... ALDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT